Zabrina Watkins named diversity, equity, and inclusion director for Prime Therapeutics

March 28, 2022

Prime Therapeutics (Prime) recently named Zabrina Watkins its new diversity, equity and inclusion (DEI) director.

“At Prime, we’re committed to fostering a culture of inclusion, where everyone feels they can belong and thrive,” said Watkins. “This year we published our first DEI transparency report, highlighting steps we’ve taken toward enhancing workplace inclusion and pledging to continue this important journey,” Watkins added.

Effective March 1, 2022, Watkins assumed the role to build on current and future DEI initiatives for Prime. At Prime, Watkins previously served as co-chair for Prime’s Diversity & Inclusion (D&I) Council and now serves on its Alumni Board. Watkins also currently serves as a lead for Prime’s Black Professionals + Allies employee resource group.

“I am humbled to take on the role of DEI director,” Watkins said. “And I look forward to continuing to build upon the solid foundation and framework for strategies, programs and initiatives that reinforce Prime’s commitment to a more equitable and inclusive organization.”

Prime’s commitment to diversity, equity and inclusion is rooted in its collective values as a company and inseparable from Prime’s purpose and dedication to serving others. Going forward, Prime will further its mission to champion DEI awareness, outreach and events, engaging its employees on a journey toward making workplace inclusion a part of its DNA.

Related news

Stories

September 16, 2022

Sirtify cultivates Black male teachers to increase representation in K-12 classrooms

As enrollees in the Sirtify program, Black male students aspiring to be K-12…

Stories

September 12, 2022

Prime ranks No. 3 on list of Minnesota’s top private companies 

Prime Therapeutics (Prime) was among the top companies named by Minneapolis/St. Paul Business…

Stories

August 17, 2022

Giving Joy to Youth in Need

Who is the face of homelessness? One might think of a person on…